4月28日,药明康德(02359)公布了2025年第一季度业绩报告。4月28日,药明康德(02359)公布了2025年第一季度业绩报告。报告显示,公司一季度整体收入96.5亿元,同比增长21%;与此同时,三个口径下利润均实现双位数增长。值得注意的是,持续经营业务在手订单达到523.3亿元,较去年同期增长47.1%。根据此前公司在业绩交流会上所披露的信息来看,公司在手订单主要的增长来自于小分子和新...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.